Clinical Statistics
We offer pharmaceutical, biotech, medical device companies or contract research organisations the opportunity to take advantage of our statistical expertise. Read more
Pharmacokinetics/-dynamics
Pharmacokinetics and -dynamics play a crucial role in early clinical development. We analyse these data with WinNonlin and SAS software. Read more
Translational Medicine & Biomarkers
The translational medicine approach is indispensable for future drug development. We offer support with our experienced staff in that field. Read more
Health Technology Assessment (HTA)
Staburo provides dossier support for submission to HTA authorities, such as IQWiG or NICE. Read more
Statistical Programming with CDISC
We provide statistical programming with SAS and R for clinical projects, including ADaM and SDTM standards for submissions. Read more
Non-clinical Statistics
Staburo offers statistics for medical device companies and non-clinical projects that require statistical support. Read more
Data analysis, clinical biostatistics and more.
Company founded in
Employees
Percent employees with university degree
Projects
Solutions
Consulting
Staburo supports clients in all biostatistics and statistical programming questions and helps to find solutions. Read more
Outsourcing
We cover a wide range of statistical services and manage entire biostatistics projects for our clients on a flexible basis. Read more
Insourcing
Staburo biostatisticians support R&D departments in case of work peaks or if external expertise is needed. Read more
Beyond Biostatistics
Our team members are experts in biostatistics. Beyond that, we are experienced in project work, working on different infrastructures and with complex processes.
Communication
You will have a single point of contact for your biostatistics needs. A personal on-site contact is often the start for a long and efficient collaboration. Read more
Project Experience
We are used to working on different IT infrastructures. Additionally, we have knowledge of terminology and key processes in interdisciplinary and/or international teams. Read more
Staburo Client Segments
- Pharma
- CROs
- Biotech, Medical Device companies, etc.
Why Staburo?
Biostatistics experts
Temporally and spatially flexible
Experienced in pharma processes
Check out our latest news!
Staburo supported successful biosimilar development program
Staburo supported Neulasta® biosimilar development (Pelmeg®) Together with Cinfa Biotech GmbH (now Mundipharma Biologics) and the University of Lucerne, Staburo recently published the first part of the results for Pelmeg®, a biosimilar for Neulasta® which is used for...
Staburo supported PD-L1 assay comparability study
PD-L1 assay comparability study published Staburo supported the evaluation of the first multicentric analytical comparability study of PD-L1 expression in urothelial bladder cancer using four clinically developed immunohistochemistry assays. Statistical analyses...
OTTO: an R Shiny App for Standardized Detection of Outliers in Bioassay Development
R Shiny App for Standardized Detection of Outliers in Bioassay Development The availability of reliable and sensitive assays is an important building block in the production and quality control of biological products. In the development of such assays, unusual or...